Ajanta Pharma records India's largest CPR campaign, Gets Recognised by Asia Book of Records MD Brand Connect30 March 2023 4:02 PM ISTMumbai: Ajanta Pharma, a specialty pharmaceutical formulation company, made it to the Asia Book of Records by conducting the largest life-saving CPR...
Govt to expand coverage of Jan Aushadhi scheme Pooja Bhatia Bhatia28 Jan 2016 8:57 AM ISTThe government is all set to provide relief to patients by expanding the coverage of its Jan Aushadhi scheme. As a result, there will be a discount...
Shortage of drug inspectors hurting pharma exports:Assocham Pooja Bhatia Bhatia11 Dec 2015 12:57 PM ISTIndian pharmaceutical sector is facing regulatory hurdles in the international markets, including the US, due to shortage of skilled drug inspectors,...
BioAtla Enters Into Strategic License And Option Agreement With Pfizer For A New Class Of Antibody Therapeutics Pooja Bhatia Bhatia10 Dec 2015 10:08 AM ISTBioAtla LLC, a biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics, today announced that it...
NeoBiocon Partners with Novartis to Offer Vildagliptin for Diabetics in UAE Pooja Bhatia Bhatia10 Dec 2015 10:01 AM ISTNeoBiocon, a collaboration between Asia's leading biopharmaceuticals company Biocon Ltd and Dr. B.R. Shetty, Chairman of the UAE-based Neopharma,...
Pfizer and Allergan: The biggest Merger of all times Pooja Bhatia Bhatia23 Nov 2015 1:57 PM ISTA whopping $150 billion amount will form the world's largest pharma entity; after Pfizer and Allergan PLC board members likely to strike the...
No fixation of price for 98 drugs identified by NPPA Pooja Bhatia Bhatia3 Nov 2015 10:55 AM ISTNPPA had earlier identified and prepared a list of fixing the price for 98 drugs used for treating various diseases such as such as tuberculosis,...
Merck KGaA to focus on its oncology business Pooja Bhatia Bhatia13 Oct 2015 11:11 AM ISTAfter the falling business of its flagship drug Rebif, used for multiple sclerosis, Merck KGaA is now betting its fortunes on its oncology business to...
